IceCure Medical Ltd
NASDAQ:ICCM
0.78 (USD) • At close October 29, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3.229 | 3.085 | 4.138 | 4.085 | 1.658 | 1.072 | 0.689 | 0.625 | 0.763 | 1.069 | 0.355 |
| Cost of Revenue
| 1.929 | 1.64 | 1.943 | 1.426 | 1.081 | 0.623 | 0.514 | 0.404 | 0.486 | 0.692 | 0.454 |
| Gross Profit
| 1.3 | 1.445 | 2.195 | 2.658 | 0.576 | 0.449 | 0.175 | 0.221 | 0.277 | 0.376 | -0.099 |
| Gross Profit Ratio
| 0.403 | 0.468 | 0.53 | 0.651 | 0.348 | 0.419 | 0.254 | 0.354 | 0.363 | 0.352 | -0.28 |
| Reseach & Development Expenses
| 8.273 | 9.123 | 5.877 | 4.079 | 2.847 | 1.941 | 1.498 | 1.664 | 0.981 | 1.006 | 0.847 |
| General & Administrative Expenses
| 7.392 | 5.857 | 4.125 | 1.759 | 1.317 | 1.066 | 1.022 | 0.944 | 1.34 | 1.299 | 1.16 |
| Selling & Marketing Expenses
| 1.211 | 3.204 | 1.917 | 1.111 | 1.02 | 0.613 | 0.32 | 0.717 | 1.485 | 2.166 | 1.646 |
| SG&A
| 8.603 | 9.061 | 6.042 | 2.87 | 2.338 | 1.678 | 1.342 | 1.661 | 2.825 | 3.466 | 2.806 |
| Other Expenses
| -0.05 | 0 | 0 | 0.071 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 16.876 | 18.184 | 11.919 | 7.02 | 5.185 | 3.619 | 2.84 | 3.325 | 3.806 | 4.472 | 3.653 |
| Operating Income
| -15.576 | -16.739 | -9.724 | -4.362 | -4.609 | -3.17 | -2.665 | -3.104 | -3.529 | -4.096 | -3.752 |
| Operating Income Ratio
| -4.824 | -5.426 | -2.35 | -1.068 | -2.78 | -2.958 | -3.866 | -4.962 | -4.626 | -3.833 | -10.581 |
| Total Other Income Expenses Net
| 0.924 | -0.239 | -0.171 | -0.329 | -0.165 | -1.37 | -0.733 | -0.641 | -0.87 | -2.408 | -2.864 |
| Income Before Tax
| -14.652 | -16.978 | -9.895 | -4.69 | -4.774 | -3.534 | -2.876 | -3.27 | -3.752 | -4.714 | -4.575 |
| Income Before Tax Ratio
| -4.538 | -5.503 | -2.391 | -1.148 | -2.88 | -3.297 | -4.172 | -5.228 | -4.918 | -4.411 | -12.9 |
| Income Tax Expense
| 0.155 | 0.239 | 0.171 | 0.087 | -0.014 | -1.131 | -0.641 | -0.459 | -0.614 | -1.799 | -2.376 |
| Net Income
| -14.652 | -17.217 | -10.066 | -4.777 | -4.76 | -3.534 | -2.876 | -3.27 | -3.752 | -4.714 | -4.575 |
| Net Income Ratio
| -4.538 | -5.581 | -2.433 | -1.17 | -2.872 | -3.297 | -4.172 | -5.228 | -4.918 | -4.411 | -12.9 |
| EPS
| -0.32 | -0.47 | -0.35 | -0.28 | -0.35 | -0.3 | -0.46 | -0.62 | -1.15 | -3.69 | -7.7 |
| EPS Diluted
| -0.32 | -0.47 | -0.35 | -0.28 | -0.35 | -0.3 | -0.46 | -0.62 | -1.15 | -3.69 | -7.7 |
| EBITDA
| -15.253 | -16.491 | -9.597 | -4.337 | -4.632 | -3.422 | -2.75 | -3.034 | -3.433 | -3.992 | -3.948 |
| EBITDA Ratio
| -4.724 | -5.346 | -2.319 | -1.062 | -2.794 | -3.192 | -3.99 | -4.85 | -4.5 | -3.735 | -11.133 |